Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

HIV antiretroviral prophylaxis for injecting drug users.

Miller WC, Hoffman IF, Latkin CA, Strathdee SA, Shoptaw S.

Lancet. 2013 Sep 7;382(9895):853. doi: 10.1016/S0140-6736(13)61854-1. No abstract available.

PMID:
24012262
2.

HIV antiretroviral prophylaxis for injecting drug users.

Craig AP, Gray R, Jansson J, Wilson DP.

Lancet. 2013 Sep 7;382(9895):854-5. doi: 10.1016/S0140-6736(13)61856-5. No abstract available.

PMID:
24012263
3.

HIV antiretroviral prophylaxis for injecting drug users.

Hudgens MG, Cole SR.

Lancet. 2013 Sep 7;382(9895):853. doi: 10.1016/S0140-6736(13)61853-X. No abstract available.

PMID:
24012261
4.

HIV antiretroviral prophylaxis for injecting drug users.

Zhiliang H, Yongfeng Y.

Lancet. 2013 Sep 7;382(9895):853-4. doi: 10.1016/S0140-6736(13)61855-3. No abstract available.

PMID:
24012260
5.

HIV antiretroviral prophylaxis for injecting drug users - Authors' reply.

Choopanya K, Martin M, Vanichseni S, Mock PA, Suntharasamai P, Sangkum U.

Lancet. 2013 Sep 7;382(9895):855. doi: 10.1016/S0140-6736(13)61857-7. No abstract available.

PMID:
24012264
6.

HIV pre-exposure prophylaxis in injecting drug users.

Karim SS.

Lancet. 2013 Jun 15;381(9883):2060-2. doi: 10.1016/S0140-6736(13)61140-X. Epub 2013 Jun 13. No abstract available.

PMID:
23769217
7.

Prophylactic tenofovir reduced HIV infection in injectable drug users.

Bender BS.

Ann Intern Med. 2013 Sep 17;159(6):JC8. doi: 10.7326/0003-4819-159-6-201309170-02008. No abstract available.

PMID:
24042391
8.

Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):463-5.

9.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Kitisin P, Natrujirote P, Kittimunkong S, Chuachoowong R, Gvetadze RJ, McNicholl JM, Paxton LA, Curlin ME, Hendrix CW, Vanichseni S; Bangkok Tenofovir Study Group.

Lancet. 2013 Jun 15;381(9883):2083-90. doi: 10.1016/S0140-6736(13)61127-7. Epub 2013 Jun 13.

PMID:
23769234
10.

Preexposure prophylaxis reduces HIV risk in injection-drug users.

Rosenberg K.

Am J Nurs. 2013 Sep;113(9):17. doi: 10.1097/01.NAJ.0000434163.23256.f7. No abstract available.

PMID:
23985594
11.

Antiretroviral preexposure prophylaxis for preventing HIV infection in high-risk individuals.

Saguil A.

Am Fam Physician. 2013 Aug 1;88(3):172-3. No abstract available.

12.

Tenofovir helps prevent HIV in drug users.

[No authors listed]

BMJ. 2013 Jun 18;346:f3871. doi: 10.1136/bmj.f3871. No abstract available.

PMID:
23777811
13.
14.

Antiretroviral prophylaxis for HIV prevention reaches a key milestone.

Karim SS, Karim QA.

Lancet. 2012 Jun 2;379(9831):2047-8. doi: 10.1016/S0140-6736(12)60786-7. Epub 2012 May 18. No abstract available.

PMID:
22608193
15.

AIDS clinical trials. More woes for novel HIV prevention approach.

Cohen J.

Science. 2005 Mar 18;307(5716):1708. No abstract available.

PMID:
15774734
16.

Pre-exposure prophylaxis for HIV infection: what if it works?

Paxton LA, Hope T, Jaffe HW.

Lancet. 2007 Jul 7;370(9581):89-93. Review. No abstract available.

PMID:
17617276
17.

The trials of tenofovir trials.

[No authors listed]

Lancet. 2005 Mar 26-Apr 1;365(9465):1111. No abstract available.

PMID:
15799093
18.

Unethical clinical trials in Thailand: a community response.

Jintarkanon S, Nakapiew S, Tienudom N, Suwannawong P, Wilson D.

Lancet. 2005 May 7-13;365(9471):1617-8. No abstract available.

PMID:
15885287
19.

Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India.

Iqbal HS, Solomon SS, Madhavan V, Solomon S, Balakrishnan P.

J Int Assoc Physicians AIDS Care (Chic). 2009 Sep-Oct;8(5):323-7. doi: 10.1177/1545109709341854. Epub 2009 Aug 31.

PMID:
19721100
20.

The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.

Chua A, Ford N, Wilson D, Cawthorne P.

PLoS Med. 2005 Oct;2(10):e346. Epub 2005 Oct 25. No abstract available.

Supplemental Content

Support Center